We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Sector Composition

Rank Sector Weight
1 Financials 22.64%
2 Technology 16.18%
3 Consumer Discretionary 11.16%
4 Industrials 10.33%
5 Healthcare 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANA
2501
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$121K ﹤0.01%
12,295
FNVT
2502
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$120K ﹤0.01%
11,857
+27
+0.2% +$271
SVNAU
2503
DELISTED
7 Acquisition Corp Unit
SVNAU
$119K ﹤0.01%
11,696
-100
-0.8% -$1.01K
HNST icon
2504
The Honest Company
HNST
$586M
$118K ﹤0.01%
+33,700
New +$124K
NINE
2505
DELISTED
Nine Energy Service
NINE
$118K ﹤0.01%
44,300
+32,800
+285% +$92.4K
DBD
2506
DELISTED
Diebold Nixdorf Incorporated
DBD
$118K ﹤0.01%
+48,700
New +$163K
SPGS
2507
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
$118K ﹤0.01%
12,000
-14,188
-54% -$140K
BSQR
2508
DELISTED
BSQUARE Corporation
BSQR
$118K ﹤0.01%
102,200
-500
-0.5% -$639
VYGR icon
2509
Voyager Therapeutics
VYGR
$201M
$117K ﹤0.01%
19,900
-7,000
-26% -$44.8K
ALORU
2510
DELISTED
ALSP Orchid Acquisition Corp I Unit
ALORU
$117K ﹤0.01%
11,629
DHX icon
2511
DHI Group
DHX
$173M
$116K ﹤0.01%
21,600
-14,310
-40% -$74.9K
BCAB icon
2512
BioAtla
BCAB
$5.74M
$115K ﹤0.01%
298
-626
-68% -$205K
VRAX icon
2513
Virax Biolabs
VRAX
$2.38M
$115K ﹤0.01%
+146
New +$241K
NUVB icon
2514
Nuvation Bio
NUVB
$2.32B
$114K ﹤0.01%
51,000
-14,300
-22% -$40.8K
ECVT icon
2515
Ecovyst
ECVT
$1.14B
$113K ﹤0.01%
+13,400
New +$127K
MTW icon
2516
Manitowoc
MTW
$675M
$113K ﹤0.01%
+14,606
New +$148K
NPKI
2517
NPK International
NPKI
$1.14B
$112K ﹤0.01%
44,300
-4,900
-10% -$14.4K
ARHS icon
2518
Arhaus
ARHS
$1.36B
$111K ﹤0.01%
15,700
-21,400
-58% -$152K
DOCS icon
2519
PUT
Doximity
DOCS
$4.88B
$111K ﹤0.01%
+112,500
New +$4.12M
PSQH icon
2520
PSQ Holdings
PSQH
$14.7M
$111K ﹤0.01%
757
-3
-0.4% -$438
RRGB icon
2521
Red Robin
RRGB
$152M
$111K ﹤0.01%
16,500
-21,686
-57% -$177K
SO icon
2522
CALL
Southern Company
SO
$107B
$110K ﹤0.01%
+200,000
New +$15.2M
ATRA icon
2523
Atara Biotherapeutics
ATRA
$76.1M
$109K ﹤0.01%
+1,154
New +$130K
ICU icon
2524
SeaStar Medical
ICU
$13.1M
$109K ﹤0.01%
43
SANBU
2525
DELISTED
Sanaby Health Acquisition Corp. I Unit
SANBU
$109K ﹤0.01%
10,779
-7,721
-42% -$78.2K

Similar funds

Schonfeld Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Schonfeld Strategic Advisors held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Schonfeld Strategic Advisors deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Schonfeld Strategic Advisors added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Schonfeld Strategic Advisors fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Schonfeld Strategic Advisors opened 939 new positions and closed 491 in Q3 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.